Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma

被引:0
|
作者
Antonio Cuadrado
Aitor Orive
Covadonga García-Suárez
Agustín Domínguez
Jose Carlos Fernández-Escalante
Javier Crespo
Fernando Pons-Romero
机构
来源
Obesity Surgery | 2005年 / 15卷
关键词
OBESITY; LIVER; STEATOSIS; HEPATOCELLULAR CARCINOMA; INSULIN RESISTANCE; DIABETES;
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is characterized by an excessive accumulation of fatty acids and triglycerides within the cytoplasm of the hepatocytes of non-alcohol users. The natural history varies according to the initial histological diagnosis. A current consideration is that cryptogenic cirrhosis may be representative of a late stage of non-alcoholic steatohepatitis (NASH), which has lost its features of necroinflammatory activity and steatosis in up to 80% of patients. Since NASH is able to progress to cirrhosis, hepatocellular carcinoma (HCC) development may be an end-stage of this disease. We report below two clinical cases of patients diagnosed with NASH who developed HCC. The relationship between NAFLD and HCC is reviewed.
引用
收藏
页码:442 / 446
页数:4
相关论文
共 50 条
  • [31] A novel mouse model of maternal overnutrition-induced non-alcoholic steatohepatitis (NASH)/hepatocellular carcinoma
    Takiyama, Y.
    Nakamura, M.
    Sera, T.
    Uesugi, K.
    Hoshino, M.
    Yagi, N.
    Haneda, M.
    DIABETOLOGIA, 2017, 60 : S577 - S578
  • [32] Effect of phlebotomy on non-alcoholic steatohepatitis (NASH).
    Nitecki, J
    Jackson, FW
    Allen, ML
    Farr, VL
    Jackson, FW
    GASTROENTEROLOGY, 2000, 118 (04) : A1474 - A1474
  • [33] Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
    Ip, Blanche C.
    Wang, Xiang-Dong
    NUTRIENTS, 2014, 6 (01) : 124 - 162
  • [34] Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
    Arndt Weinmann
    Yvonne Alt
    Sandra Koch
    Carina Nelles
    Christoph Düber
    Hauke Lang
    Gerd Otto
    Tim Zimmermann
    Jens U Marquardt
    Peter R Galle
    Marcus A Wörns
    Jörn M Schattenberg
    BMC Cancer, 15
  • [35] Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
    Kessler, Sonja M.
    Simon, Yvette
    Gemperlein, Katja
    Gianmoena, Kathrin
    Cadenas, Cristina
    Zimmer, Vincent
    Pokorny, Juliane
    Barghash, Ahmad
    Helms, Volkhard
    van Rooijen, Nico
    Bohle, Rainer M.
    Lammert, Frank
    Hengstler, Jan G.
    Mueller, Rolf
    Haybaeck, Johannes
    Kiemer, Alexandra K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (04) : 5762 - 5773
  • [36] Progression of disease in non-alcoholic steatohepatitis (NASH)
    Kaplan, KJ
    Katz, DE
    Holtzmuller, KC
    Sjogren, MH
    Goodman, ZD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 164A - 164A
  • [37] Laboratory predictors of non-alcoholic steatohepatitis (NASH)
    Bilici, A
    Unsal, B
    McGee, A
    Bolukoglu, H
    Ankoma-Sey, V
    Edwards, M
    HEPATOLOGY, 1999, 30 (04) : 438A - 438A
  • [38] Disparities in Hospitalizations for Women With Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
    Mills, Krystal
    Igwe, Joseph
    Abe, Temidayo
    Sobukonla, Timothy
    Bilal, Muhammad
    Dixit, Devika
    Jordan, Ariel
    Surapaneni, Phani Keerthi
    Bakinde, Nicolas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1709 - S1709
  • [39] The Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated with Non-Alcoholic Steatohepatitis
    Busler, J. F.
    Geevarghese, S. K.
    Kelly, B. S.
    Washington, M. K.
    MODERN PATHOLOGY, 2012, 25 : 412A - 412A
  • [40] Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
    Pinyol, Roser
    Torrecilla, Sara
    Wang, Huan
    Montironi, Carla
    Pique-Gili, Marta
    Torres-Martin, Miguel
    Wei-Qiang, Leow
    Willoughby, Catherine E.
    Ramadori, Pierluigi
    Andreu-Oller, Carmen
    Taik, Patricia
    Lee, Youngmin A.
    Moeini, Agrin
    Peix, Judit
    Faure-Dupuy, Suzanne
    Riedl, Tobias
    Schuehle, Svenja
    Oliveira, Claudia P.
    Alves, Venancio A.
    Boffetta, Paolo
    Lachenmayer, Anja
    Roessler, Stephanie
    Minguez, Beatriz
    Schirmacher, Peter
    Dufour, Jean-Francois
    Thung, Swan N.
    Reeves, Helen L.
    Carrilho, Flair J.
    Chang, Charissa
    Uzilov, Andrew, V
    Heikenwalder, Mathias
    Sanyal, Arun
    Friedman, Scott L.
    Sia, Daniela
    Llovet, Josep M.
    JOURNAL OF HEPATOLOGY, 2021, 75 (04) : 865 - 878